[BioS] Hanall Biopharma 3Q revenue ₩39.9B, "down 2.2% YoY"
Predicted impact: Low
Q3 revenue ₩39.9B, down 2.2%; results were already reported via preliminary earnings.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.